-
-
- Nov 13/26
Photoacoustic imaging enables real-time stem cell tracking in regenerative medicine - Nov 12/26
Placental stem cell therapy shows promise for diabetic foot ulcers - Nov 11/26
New research hub to focus on innovative cell and gene therapies - Nov 11/26
Experimental cell therapy helps ordinary skin mimic tough palm tissue - Nov 11/26
The BioPharm Brief: Base editing hits its mark in sickle cell, a Phase 3 win in Sjögren’s, and off-the-shelf CAR-T in lupus - Nov 11/26
Epilepsy: Understanding the condition and exploring new treatments - Nov 10/26
Extramedullary relapse linked to poorer survival after CAR-T in myeloma - Nov 9/26
CGT Catapult chief executive Matthew Durdy to retire in 2027 - Nov 9/26
Experimental treatment promotes repair after heart attack damage - Nov 8/26
CAR T-cell therapy shows promise for difficult-to-treat lupus - Nov 8/26
Injured Wainwright soldiers benefit from cutting-edge Canadian burn research - Nov 8/26
Weekly reads: Huntington’s treatment hope, AI & the idea of a science paper, misuse of 3-parent IVF (MRT), death of young stem cell biologist - Nov 7/26
Genome sequencing tracks mutations in stem cells grown for months - Nov 6/26
The changing world of animal cloning - Nov 6/26
Math model shows CAR T-cell therapy outperforms chemotherapy against leukemia - Nov 6/26
Blood-based scores and immune biomarkers reshape outcome prediction in blood cancers - Nov 6/26
Rubidium chloride ultracentrifugation resolves and quantifies dual-AAV gene therapy vectors - Nov 4/26
Naive-like T cells linked to CAR T durability - Nov 4/26
How a CRISPR sickle cell therapy moved from lab to clinical trial - Nov 4/26
Two gene therapy approvals expand options for rare immune disorders as access challenges persist - Nov 4/26
Natural compounds show promise against breast cancer stem cells - Nov 3/26
2 new FDA warning letters with an odd one for totipotent stem cells & Laennec - Nov 3/26
Squeezing cells loosens DNA, boosts CRISPR efficiency - Nov 2/26
Cell therapy investment grows as safety events rankle Big Pharma’s CAR T autoimmune push - Nov 2/26
Seeing advanced therapies in a different light with flow cytometry - Nov 2/26
Can Saudi Arabia’s burgeoning biotech hub withstand geopolitical pressures? - Oct 31/26
Weekly reads: ER-100 trial update, ND AG stem cell alert, autoimmune CAR-T hurdles, AI effects on biologists, No on Prop 38 - Oct 30/26
From brittle bones to gene editing: New map of osteogenesis imperfecta and its therapies - Oct 30/26
Stem cell exosome fracture healing study retracted over image integrity concerns - Oct 29/26
Aspen raises a $141M IPO in pursuit of a cell therapy for Parkinson’s - Oct 29/26
Activating cancer-fighting protein could make T-cell immunotherapies more effective, study finds - Oct 29/26
Gene therapy halves key DNA repair signal in primate brains, model predicts slower Huntington’s progression - Oct 29/26
Japan bans heritable genome editing with criminal penalties - Oct 29/26
First continuous cell lines end six-decade quest to culture marine invertebrate cells - Oct 28/26
CRISPR gene therapies face a reckoning with off-target genome edits - Oct 27/26
New [uOttawa-led] study takes aim at bridging the gap between the laboratory and the clinic - Oct 27/26
Transient early-pluripotency treatment yields human iPSCs with stronger differentiation - Oct 27/26
After two deaths in autoimmune cell therapy trial, Artiva is shutting down - Oct 26/26
Another autoimmune CAR-T death; Treasury zeroes in on China deals - Oct 26/26
Takahashi wins 2026 prize for iPS cell Parkinson’s therapy - Oct 26/26
Government of Canada announces major investment in Canadian researchers and research institutions - Oct 25/26
CAR T cells shrink lymphoma everywhere, but survival depends on location - Oct 23/26
Canada’s HIV moonshot to ‘tickle’ the virus out of hiding - Oct 22/26
Review positions crosslinking as a multidimensional regulator of regenerative biomaterials - Oct 22/26
Clinical trial setup times fall sharply in U.K. - Oct 22/26
AI model decodes the language cells use to communicate - Oct 21/26
TCR-engineered T cells advance toward harder liver cancer targets - Oct 21/26
Stem-cell craniofacial therapy shows similar early patient-reported outcomes - Oct 21/26
Spanish survey finds high DMD gene-therapy willingness amid readiness gaps - Oct 20/26
Stem cell therapies improve tendon-bone healing in ACL animal models - Oct 20/26
Experts weigh risks of using gene therapies for common diseases - Oct 20/26
Global stem cell research community gathers in Kyoto, Japan to celebrate 20 years of iPSC discovery and innovation - Oct 19/26
From cells to organoids: Cytokines that shape 3D culture - Oct 19/26
Blood cell crashes after CAR-T therapy follow a predictable risk score, study finds - Oct 18/26
Weekly reads: G&D trio, Regenative Labs sues FDA, OCT4 sub, SpudCells, SRSF1 as an anti-aging factor? - Oct 18/26
Bacterial peptide-primed stem cell vesicles push colon cancer cells toward suicide - Oct 18/26
Single gene knockout strips lab-grown heart cells of immune visibility - Oct 18/26
CAR T-cell therapy may spare older patients’ memory more than younger ones - Oct 16/26
Engineered immune cells push cancer therapy into its next frontier - Oct 16/26
Scientists discover a molecular switch that drives T-cell exhaustion in cancer immunotherapy - Oct 15/26
FDA’s latest rare disease framework seeks to prioritize consistency in flexibility - Oct 15/26
Proof-of-concept for hydrocephalus gene therapy that could reduce reliance on shunts - Oct 15/26
Belgian startup revives Galapagos CAR-T research - Oct 15/26
Reprogramming gene expression networks could reverse biological aging - Oct 14/26
USC launches first-in-human trial of cartilage-protecting knee injection - Oct 14/26
Enhanced CAR T-cell therapy shows promise in trial for B-cell blood cancers - Oct 13/26
Lipid nanoparticles reprogram natural killer cells inside the body to fight cancer - Oct 13/26
DNA recording system reveals how a single cell becomes a body - Oct 12/26
Caribou halts allogeneic CAR T programs as funding pressures mount - Oct 12/26
FDA clears Phase 2 trial of B7-H3 CAR T MT027 for brain metastases - Oct 12/26
Immune signal IL-18 supercharges rare T cells for solid tumour therapy - Oct 12/26
The BioPharm Brief: Trials test CAR-T, immunology and targeted oncology - Oct 12/26
RNA edit swaps out OCT4 to make better stem cells - Oct 12/26
Donor-derived CD19 CAR-T cells deliver lasting remissions in leukemia patients after transplant failure - Oct 9/26
One researcher’s quest to cure neurodegenerative diseases gets personal - Oct 8/26
Canadian children’s hospitals expand AI-powered rare disease detection as gene therapy research advances - Oct 8/26
Reusing data could cut R&D costs and greatly increase gene editing’s reach: ARM - Oct 8/26
Activated protein C keeps blood stem cells resting and boosts transplant success - Oct 8/26
Inhaled stem cells for COPD: What would prove lasting benefit? - Oct 7/26
Metabolism holds the key to stronger CAR T cell therapies, review argues - Oct 7/26
Atsena’s Lighthouse gene therapy readout illuminates eye disease efficacy - Oct 6/26
Why the mouth matters: Dentists join the CAR-T therapy team - Oct 6/26
Platelet-powered cartilage cells move closer to the clinic with a new GMP blueprint - Oct 6/26
Viruses that board CAR cells: A modular push against solid tumours
- Nov 13/26
-
